DEFA14A: CompoSecure to Acquire Husky Technologies in $3.95B Deal

Sentiment:

Merger Announcement


CompoSecure, Inc. announced a definitive agreement to acquire Husky Technologies Limited for approximately $3.953 billion in cash and 55,297,297 shares of Class A Common Stock, making Husky an indirect wholly-owned subsidiary.

Delay expectedThe closing date is no later than six (6) months after the Agreement Date (November 2, 2025), setting an outside termination date of May 2, 2026.The transaction may be terminated if the required approvals, including regulatory clearances and Company Stockholder Approval, are not obtained.Termination can occur if any permanent injunction or other order from a governmental entity prevents the consummation of the Transactions.
Capital raiseA private placement (PIPE) was entered into concurrently with the acquisition agreement.CompoSecure agreed to issue and sell 106,056,083 shares of its Common Stock to certain investors.The purchase price for the PIPE shares is $18.50 per share.The aggregate purchase price for the PIPE is approximately $1.96 billion.The closing of the Private Placement is conditioned upon the concurrent consummation of the acquisition transactions.

Summary

  • CompoSecure, Inc. and its subsidiaries entered into a Share Purchase Agreement to acquire Husky Technologies Limited for approximately $3.953 billion in cash and 55,297,297 shares of CompoSecure's Class A Common Stock.
  • Following the closing of the transactions, Husky Technologies Limited will become an indirect wholly-owned subsidiary of CompoSecure.
  • The transaction is subject to various closing conditions, including approval from a majority of CompoSecure's stockholders for the issuance of the stock consideration and regulatory clearances.
  • Concurrently with the acquisition agreement, CompoSecure entered into purchase agreements for a private placement (PIPE) of 106,056,083 shares of its Common Stock at a price of $18.50 per share, raising approximately $1.96 billion.
  • A Voting Agreement has been executed by certain stockholders, including entities affiliated with Platinum Equity, representing approximately 41.3% of CompoSecure's outstanding Common Stock as of September 10, 2025, committing them to vote in favor of the stock issuance.
  • An Investor Rights Agreement will grant Platinum Equity the right to nominate directors to CompoSecure's Board of Directors post-closing, based on its ownership percentage.
  • A Management Agreement will be established with Resolute Holdings Management, Inc. to provide management services to Husky's business following the acquisition.

Sentiment

Score: 7

Explanation: The acquisition of Husky Technologies is a significant strategic move for CompoSecure, offering substantial growth potential through diversification into industrial manufacturing. The board's unanimous approval and a strong voting agreement from key shareholders indicate internal confidence. However, the large cash and stock consideration, potential for regulatory 'Burdensome Conditions,' and the inherent complexities of integrating a large, diverse business introduce considerable execution risk. The PIPE financing secures a portion of the funding but also leads to significant dilution.

Positives

  • The acquisition of Husky Technologies represents a significant strategic expansion for CompoSecure into industrial manufacturing, potentially diversifying its revenue streams and market reach.
  • CompoSecure's Board of Directors has unanimously approved the transaction and resolved to recommend stockholder approval for the necessary stock issuance.
  • A Voting Agreement from stockholders representing approximately 41.3% of outstanding Common Stock as of September 10, 2025, increases the likelihood of obtaining the required stockholder approval.
  • The Investor Rights Agreement provides Platinum Equity with board nomination rights, which can help align the interests of a major investor with the company's long-term strategy.
  • The PIPE investment of approximately $1.96 billion provides substantial capital to help fund the acquisition.

Negatives

  • The transaction requires approval from a majority of CompoSecure's stockholders for the issuance of the stock consideration, which is a potential hurdle.
  • The acquisition is subject to various closing conditions, including regulatory clearances, which could lead to delays or impose 'Burdensome Conditions' that materially affect the combined entity.
  • The issuance of 55,297,297 shares for the acquisition and 106,056,083 shares for the PIPE will result in significant dilution for existing CompoSecure shareholders.
  • The transaction involves substantial debt financing, which introduces financial risk to the combined entity.

Risks

  • The risk that the Transactions may not be completed in a timely manner or at all.
  • Failure to obtain required approvals, including regulatory approvals and the Company Stockholder Approval.
  • The occurrence of any event that could give rise to termination of the Share Purchase Agreement.
  • The effect of the announcement, pendency, or consummation of the Transactions on the parties' business relationships, operations, financial, and accounting matters.
  • Risks that the expected benefits of the Transactions, including financial projections, estimates, and outlook, may not be fully realized or may take longer to realize than expected.
  • Risks related to financing the Transactions.
  • Costs related to the Transactions.
  • Potential litigation and/or regulatory actions relating to the Transactions.
  • General economic, market, industry, and competitive conditions.
  • The imposition of 'Burdensome Conditions' by regulatory authorities, such as required divestitures or limitations on business conduct, which could materially adversely affect the Acquired Companies or Parent.
  • Other risks and uncertainties described in CompoSecure's filings with the Securities and Exchange Commission.

Future Outlook

The transaction is expected to result in Husky becoming an indirect wholly-owned subsidiary of CompoSecure, implying integration and continued operations under CompoSecure's umbrella. However, the filing explicitly states that the expected benefits of the Transactions, including financial projections, estimates, and outlook, may not be fully realized or may take longer to realize than expected, and are subject to various risks and uncertainties.

Management Comments

  • CompoSecure's Board of Directors has approved the Transaction Agreement, the Transactions, the Purchase Agreements, and the Company Stock Issuance, and has resolved to recommend to Company Stockholders to approve the Company Stock Issuance.
  • The Parent Board unanimously adopted resolutions approving the Agreement and the Transactions, including the Parent Stock Issuance, and recommending that Parent stockholders approve the Parent Stock Issuance.
  • The Parent Board received an opinion from Morgan Stanley & Co. LLC stating that the Base Purchase Price to be paid by Parent is fair from a financial point of view to Parent, subject to various assumptions and qualifications.

Industry Context

CompoSecure, known for its secure payment cards and authentication solutions, is undertaking a significant strategic acquisition of Husky Technologies, a leading supplier of injection molding equipment and services. This move represents a substantial diversification for CompoSecure, potentially allowing it to leverage Husky's advanced manufacturing capabilities or expand into new industrial markets. This could be interpreted as a strategy to broaden its technology portfolio beyond its core secure payment card business, seeking new avenues for growth and market presence.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
DirectorNALouis SamsonImmediately following ClosingsInvestor Designee by Platinum Equity, as per Investor Rights Agreement.
DirectorNADelara ZarrabiImmediately following ClosingsInvestor Designee by Platinum Equity, as per Investor Rights Agreement.
Directors and Officers of Acquired CompaniesVariousNAImmediately prior to ClosingsResignation as part of the acquisition, as listed on Exhibit I.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Board CompositionTwo additional directors nominated by Platinum Equity will be appointed to CompoSecure's Board of Directors, increasing Platinum Equity's representation.Immediately following ClosingsIncreases Platinum Equity's influence on CompoSecure's governance and strategic direction, reflecting its significant investment.
Investor RightsAn Investor Rights Agreement grants Platinum Equity the right to nominate directors based on its ownership percentage (two for >=10% ownership, one for >5% but <10%).Immediately following ClosingsFormalizes Platinum Equity's governance influence and provides long-term representation, potentially enhancing shareholder oversight.
Voting AgreementCertain stockholders, including Platinum Equity affiliates, representing approximately 41.3% of outstanding shares, have agreed to vote in favor of the Company Stock Issuance.November 2, 2025Significantly increases the likelihood of obtaining the necessary stockholder approval for the transaction, reducing uncertainty.
Lock-up PeriodsPlatinum Equity is subject to a 90-day lock-up period, while Resolute Compo Holdings LLC and its affiliates are subject to a 365-day lock-up period following the Closing.Immediately following ClosingsProvides stability for CompoSecure's stock price post-acquisition by restricting immediate sales from major shareholders, fostering market confidence.
Management AgreementAn indirect subsidiary of CompoSecure will enter into a management agreement with Resolute Holdings Management, Inc. to provide management and related services to Husky's business.Immediately following ClosingsEstablishes a formal management structure for the acquired entity, ensuring operational continuity and strategic oversight.
Waiver Agreement AmendmentAn amendment to the Amended and Restated Waiver Agreement ensures that if the Board Size Requirement Waiver is rescinded, the Board will increase its size to allow Platinum Equity to continue exercising its nomination rights.Immediately following ClosingsSafeguards Platinum Equity's board representation rights, reinforcing its long-term involvement in CompoSecure's governance.

Legal Proceedings

  • Potential litigation and/or regulatory actions relating to the Transactions are identified as a risk that could cause actual results to differ materially.

Related Party Transactions

  • A Voting Agreement was entered into with entities affiliated with Platinum Equity, Resolute Compo Holdings LLC, Tungsten 2024 LLC, and Ridge Valley LLC, committing them to vote in favor of the Company Stock Issuance.
  • An Investor Rights Agreement will be entered into with an affiliate of Platinum Equity, granting board nomination rights and allowing Platinum Equity and its affiliates to freely pursue any business opportunity.
  • A Registration Rights Agreement will be entered into with entities affiliated with Platinum Equity, providing customary resale, demand, and piggyback registration rights for their shares.
  • A Management Agreement will be entered into between an indirect subsidiary of CompoSecure and Resolute Holdings Management, Inc. (an affiliate of Platinum Equity) for management services to Husky's business, in exchange for quarterly management fees.
  • The First Amendment to the Amended and Restated Waiver Agreement was entered into with Resolute Compo Holdings LLC and Tungsten 2024 LLC, addressing board size and Platinum Equity's nomination rights.

Stakeholder Impact

  • Shareholders will be impacted by the need to approve the stock issuance, potential dilution from new shares, and the long-term value creation or risks associated with the acquisition.
  • Employees of Husky Technologies will become part of CompoSecure's indirect subsidiary, with continuing employees receiving comparable compensation and benefits for at least one year post-closing.
  • Customers and suppliers of both CompoSecure and Husky Technologies may experience changes in business relationships, although efforts are expected to preserve these relationships.
  • Creditors of Husky Technologies will see their existing debt (Repaid Debt) addressed through repayment or refinancing as part of the transaction.

Next Steps

  • CompoSecure plans to file a proxy statement with the SEC to seek Company Stockholder Approval for the stock issuance.
  • A Parent Stockholders Meeting will be duly called, noticed, convened, and held to obtain the Parent Stockholder Approval.
  • The parties must obtain certain regulatory clearances pursuant to merger control laws and foreign direct investment laws.
  • Completion of certain pre-Closing restructuring transactions is required.
  • The Stock Consideration and PIPE Shares must be authorized for listing on the NYSE.
  • CompoSecure must arrange and obtain the Backstop Debt Financing.
  • The Company will purchase customary directors and officers liability run-off/tail insurance.
  • CompoSecure will take all actions necessary to appoint two additional directors nominated by Platinum Equity to its Board of Directors.

Key Dates

DateDescription
March 28, 2018Date of the Target Credit Agreement.
September 24, 2018Date of the Second Amended and Restated Stockholders Agreement of the Company.
April 24, 2019Start of look-back period for certain compliance matters (Export Control Law, Sanctions).
February 12, 2024Date of the Indenture for the 9.000% Senior Secured Notes Due 2029.
April 19, 2024Date of the NAV Loan Agreement.
December 31, 2024Fiscal year end for CompoSecure's Annual Report on Form 10-K and Parent Audited Balance Sheet.
March 5, 2025CompoSecure's Annual Report on Form 10-K for fiscal year ended December 31, 2024, filed with the SEC.
March 31, 2025Resolute Holdings Annual Report on Form 10-K for fiscal year ended December 31, 2024, filed with the SEC.
April 18, 2025CompoSecure's Definitive Proxy Statement on Schedule 14A filed with the SEC.
July 12, 2025Date of the Amended and Restated Waiver Agreement.
July 14, 2025Current Reports on Form 8-K filed by CompoSecure (amended on July 17, 2025).
September 10, 2025Date for calculation of voting stockholders' ownership (41.3% of outstanding shares).
September 30, 2025Period end for unaudited consolidated financial statements, and reference date for debt and employee lists.
October 30, 2025Signing Capitalization Date for Parent's capital stock and equity awards.
November 2, 2025Date of earliest event reported, including the Share Purchase Agreement, Voting Agreement, and Private Placement agreements.
November 4, 2025Date of the Current Report on Form 8-K filing.
May 2, 2026Termination Date if the closing of the transactions has not occurred (six months after the Agreement Date).
Closing DateDate of transaction completion, to be agreed upon, no later than four business days after all conditions are satisfied or waived.

Recommendation

hold

This filing details a significant strategic acquisition and associated financing, rather than reporting on operational performance. While the acquisition of Husky Technologies could offer long-term growth and diversification for CompoSecure, it also introduces substantial integration challenges, financial leverage, and potential dilution. A 'hold' recommendation is appropriate for a seasoned investor to allow time for further analysis of the integration plan, market reception, and the realization of expected synergies, as well as to monitor the successful navigation of regulatory approvals and financing conditions. The immediate impact on share price is likely to be volatile given the scale of the transaction and the associated capital raise.

Keywords

CompoSecure, Husky Technologies, Acquisition, Merger, Corporate Governance, Capital Raise, Private Placement, PIPE, Stock Issuance, Regulatory Approval, Financial Reporting, CMPO, Platinum Equity, Injection Molding, Secure Payment Cards

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.